Taken together, these data are consistent with our results showing that her3/HES3 is a PAX3-FOXO1 target, and that HES3 contributes to a more aggressive phenotype in rhabdomyosarcoma. The gene discussed is HES3; the disease is rhabdomyosarcoma.